HRT Financial’s Otonomy, Inc. OTIC Stock Holding History

HRT Financial’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-32,790	Closed	-$212K	–	3315
2020 Q4	$212K	Buy	+32,790	New	+$149K	﹤0.01%	1476

Other funds holding OTIC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HRT Financial's OTIC Position: Q1 2021 in Review

HRT Financial sold out of Otonomy, Inc. (OTIC) in Q1 2021, closing a stake of 32,790 shares — an estimated $212K sold.

HRT Financial first reported a position in OTIC in Q4 2020 and held it in 1 quarter. The position peaked at $212K in Q4 2020. 62 funds tracked by Wall St. Rank hold OTIC as of Q1 2021.

HRT Financial reported no remaining Otonomy, Inc. position as of Q1 2021 after selling out during the quarter.
HRT Financial sold 32,790 Otonomy, Inc. shares in Q1 2021, an estimated $212K.
HRT Financial first reported a position in Otonomy, Inc. in Q4 2020 and held it in 1 quarter.
HRT Financial's Otonomy, Inc. position peaked at $212K in Q4 2020.
62 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q1 2021.

Based on HRT Financial's 13F filing for Q1 2021, filed 17 May 2021.